GLP-1 Cost Calculator:
Insurance vs. Self-Pay
Wegovy, Zepbound, and other GLP-1 medications retail for over $1,000/month. How much will you actually pay? Estimate your monthly cost based on your insurance and health profile, then compare to compounded alternatives.
Configure Your Estimate
Select your medication, insurance type, and health profile
Understanding Your GLP-1 Cost Options
Why GLP-1 Medications Cost So Much
Brand-name GLP-1 medications like Wegovy® and Zepbound® are priced between $969 and $1,387 per month at retail. This reflects the high R&D costs and limited competition in the injectable weight loss market. Without insurance or a discount program, this is simply unaffordable for most Americans.
The good news: most people paying full retail price don't have to. Insurance coverage, manufacturer savings cards, and compounded alternatives can reduce monthly costs by 80–98%.
The 3 Paths to GLP-1 Medication
Insurance Coverage
- •Typical copay: $25–$50/mo
- •Requires prior authorization
- •BMI + comorbidity criteria apply
- •May face denials and appeals
Best for: Patients with employer or commercial insurance who meet BMI criteria
Compounded GLP-1
- •Typical cost: $149–$299/mo
- •Same active ingredient
- •No prior auth required
- •Available to most patients
Best for: Patients without adequate insurance or those denied coverage
Brand Name Self-Pay
- •Retail: $969–$1,387/mo
- •Manufacturer savings cards available
- •May reduce to $200–$500/mo
- •Cards have income limits
Best for: Patients who need brand-name medication and don't qualify for insurance
How Prior Authorization Works
Most insurance plans require prior authorization (PA) before they'll cover GLP-1 medications. This is a formal review process where your provider submits medical documentation proving you meet the plan's criteria — typically a BMI of 30+ with a qualifying comorbidity, or BMI 35+ without.
PA approval is not guaranteed. Approval rates vary widely by insurer and plan, with some reporting rates of 60–70% on first submission. Denied PAs can often be appealed — and providers experienced with GLP-1 approvals, like Ro, have teams that manage this process for you.
Let Ro Handle Your PAInsurance Denied? Your Next Steps
- 1
Appeal the denial
Ask your provider to file a formal appeal with additional supporting documentation. Many first-time denials are reversed on appeal.
- 2
Try manufacturer savings programs
Novo Nordisk and Eli Lilly offer savings cards that can reduce costs to ~$200/month for commercially insured patients who don't use government insurance.
- 3
Switch to compounded GLP-1
Telehealth providers offer compounded semaglutide or tirzepatide for $149–$299/month — no insurance needed, same active ingredient.
- 4
Work with an insurance concierge
Services like Ro's insurance team navigate the PA process, appeals, and alternative options on your behalf at no added cost.
Not Sure If Your Insurance Covers GLP-1s?
Ro's insurance concierge checks your plan and confirms coverage in minutes — for free, with no commitment required.
Check My Insurance at Ro.coAffiliate link — we may earn a commission at no cost to you